SCHEMBL10195451

SCHEMBL10195451

CCc1ccc(Oc2ccc(F)c(Cl)c2)cc1C1=C(O)CC(C)(C)CC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
HTR2A P28223 2/20 0.38
SLC6A4 P31645 2/20 0.38
KCNH2 Q12809 2/20 0.38
LMNA P02545 1/20 0.36
CYP11B2 P19099 1/20 0.36
SOS1 Q07889 2/20 0.36
ALDH1A1 P00352 8/20 0.36
CTSD P07339 1/20 0.36
BACE1 P56817 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HIF1A Q16665 1/20 0.35
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10194979 0.92 SMN1; SMN2 (0.39) SMN1; SMN2HTR2ASLC6A4KCNH2LMNA
SCHEMBL10195106 0.89 ALDH1A1 (0.42) SMN1; SMN2LMNAALDH1A1HTTKMT2A
SCHEMBL16181148 0.88 SMN1; SMN2 (0.39) SMN1; SMN2HTR2ASLC6A4KCNH2LMNA
SCHEMBL10195449 0.88 SMN1; SMN2 (0.39) SMN1; SMN2LMNAALDH1A1HTTKMT2A
SCHEMBL10195109 0.87 SMN1; SMN2 (0.39) SMN1; SMN2LMNAALDH1A1HTTKMT2A
SCHEMBL10195111 0.87 SLC6A4 (0.40) SMN1; SMN2HTR2ASLC6A4KCNH2ALDH1A1
SCHEMBL10195487 0.87 ALDH1A1 (0.38) SMN1; SMN2LMNAALDH1A1HTTKMT2A
SCHEMBL16351678 0.86 SMN1; SMN2 (0.37) SMN1; SMN2LMNAALDH1A1KMT2AMEN1
SCHEMBL16351660 0.86 SMN1; SMN2 (0.36) SMN1; SMN2HTR2ASLC6A4KCNH2LMNA
SCHEMBL10195172 0.86 SLC6A4 (0.41) SMN1; SMN2HTR2ASLC6A4KCNH2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 SMN1; SMN2 2218/4885HTR2A 1192/4885SLC6A4 1501/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 SMN1; SMN2 2952/4885HTR2A 1320/4885SLC6A4 1443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.